OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
High-titer convalescent plasma plus nirmatrelvir/ritonavir treatment for non-resolving COVID-19 in six immunocompromised patients
Sammy Huygens, Arvind Gharbharan, Yasmina Serroukh, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 7, pp. 1644-1648
Open Access | Times Cited: 13
Sammy Huygens, Arvind Gharbharan, Yasmina Serroukh, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 7, pp. 1644-1648
Open Access | Times Cited: 13
Showing 13 citing articles:
Clinical and Virological Outcome of Monoclonal Antibody Therapies Across SARS-CoV-2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study
Sammy Huygens, Corine H. GeurtsvanKessel, Arvind Gharbharan, et al.
Clinical Infectious Diseases (2024) Vol. 78, Iss. 6, pp. 1514-1521
Open Access | Times Cited: 6
Sammy Huygens, Corine H. GeurtsvanKessel, Arvind Gharbharan, et al.
Clinical Infectious Diseases (2024) Vol. 78, Iss. 6, pp. 1514-1521
Open Access | Times Cited: 6
Efficacy and safety of antiviral therapies for the treatment of persistent COVID-19 in immunocompromised patients since the Omicron surge: a systematic review
Caroline Hirsch, Nina Kreuzberger, Nicole Skoetz, et al.
Journal of Antimicrobial Chemotherapy (2025)
Open Access
Caroline Hirsch, Nina Kreuzberger, Nicole Skoetz, et al.
Journal of Antimicrobial Chemotherapy (2025)
Open Access
Antiviral combination therapies for persistent COVID-19 in immunocompromised patients
Daniele Focosi, Fabrizio Maggi, Alessandra D’Abramo, et al.
International Journal of Infectious Diseases (2023) Vol. 137, pp. 55-59
Open Access | Times Cited: 17
Daniele Focosi, Fabrizio Maggi, Alessandra D’Abramo, et al.
International Journal of Infectious Diseases (2023) Vol. 137, pp. 55-59
Open Access | Times Cited: 17
How I treat: Coronavirus disease 2019 in leukemic patients and hematopoietic cell transplant recipients
Dionysios Neofytos, Nina Khanna
Transplant Infectious Disease (2024) Vol. 26, Iss. 4
Open Access | Times Cited: 3
Dionysios Neofytos, Nina Khanna
Transplant Infectious Disease (2024) Vol. 26, Iss. 4
Open Access | Times Cited: 3
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review
Paul Kinsella, Michael A. Moso, C. Orla Morrissey, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 3
Open Access | Times Cited: 1
Paul Kinsella, Michael A. Moso, C. Orla Morrissey, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 3
Open Access | Times Cited: 1
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients
Chiara Sepulcri, Claudia Bartalucci, Małgorzata Mikulska
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 506-517
Closed Access | Times Cited: 1
Chiara Sepulcri, Claudia Bartalucci, Małgorzata Mikulska
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 506-517
Closed Access | Times Cited: 1
The consequences of SARS-CoV-2 within-host persistence
Alex Sigal, Richard A. Neher, Richard Lessells
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 1
Alex Sigal, Richard A. Neher, Richard Lessells
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 1
Phylogenetic meta-analysis of chronic SARS-CoV-2 infections in immunocompromised patients shows no evidence of elevated evolutionary rates
Sanni Översti, Emily Gaul, Björn‐Erik Ole Jensen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Sanni Översti, Emily Gaul, Björn‐Erik Ole Jensen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
COVID-19: An Update on Epidemiology, Prevention and Treatment, September-2023
Serap Şimşek Yavuz
Infectious Diseases and Clinical Microbiology (2023) Vol. 5, Iss. 3, pp. 165-187
Open Access | Times Cited: 2
Serap Şimşek Yavuz
Infectious Diseases and Clinical Microbiology (2023) Vol. 5, Iss. 3, pp. 165-187
Open Access | Times Cited: 2
Antiviral therapy for COVID-19
Adamantia Liapikou, Μαρία Λερίκου
European Respiratory Society eBooks (2024)
Closed Access
Adamantia Liapikou, Μαρία Λερίκου
European Respiratory Society eBooks (2024)
Closed Access
Covid-19 : encore une place pour le plasma de convalescent ? Focus sur les patients immunodéprimés
Quentin Richier, Thomas Hueso, Pierre Tiberghien, et al.
La Revue de Médecine Interne (2023) Vol. 44, Iss. 9, pp. 467-471
Open Access | Times Cited: 1
Quentin Richier, Thomas Hueso, Pierre Tiberghien, et al.
La Revue de Médecine Interne (2023) Vol. 44, Iss. 9, pp. 467-471
Open Access | Times Cited: 1
A multinational case series describing successful treatment of persistent SARS-CoV-2 infection caused by Omicron sublineages with prolonged courses of nirmatrelvir/ritonavir.
Luke B. Snell, Aimée McGreal-Bellone, Clemency Nye, et al.
Open Forum Infectious Diseases (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Luke B. Snell, Aimée McGreal-Bellone, Clemency Nye, et al.
Open Forum Infectious Diseases (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 1
The effects of nirmatrelvir/ritonavir on tacrolimus levels in lung transplant recipients: A single-center study
Xiaoxing Wang, Wenwen Du, Dan Zhang, et al.
Pulmonary Pharmacology & Therapeutics (2023) Vol. 84, pp. 102280-102280
Closed Access
Xiaoxing Wang, Wenwen Du, Dan Zhang, et al.
Pulmonary Pharmacology & Therapeutics (2023) Vol. 84, pp. 102280-102280
Closed Access
